Sebastian Marwitz

1.2k citations
40 papers · 766 indexed · h-index 15

Sebastian Marwitz

38 papers receiving 756 citations

Peers

Sebastian Marwitz
Comparison fields: 5 of 88
  • Microbiology 86
  • Immunology 230
  • Cancer Research 127
  • Pulmonary and Respiratory Medicine 272
  • Endocrinology 39
Replace Sang Won Hyun with:
Sang Won Hyun United States
Liping Tian China
Helena Kahu Sweden
H. C. Hoogsteden Netherlands
Zvjezdana Sever-Chroneos United States
Sarah A. Mazzilli United States
Shanshan Zhang China
Hidetaka Uryu Japan
Runzi Qi China
Georgia Lagoudas United States
Sebastian Marwitz relative to Sang Won Hyun United States Sang Won Hyun's profile →
Citations per field
00.5×
Sang Won Hyun · 1×
Citations per year

Countries citing papers authored by Sebastian Marwitz

Since Specialization
Citations

This map shows the geographic impact of Sebastian Marwitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Marwitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Marwitz more than expected).

Fields of papers citing papers by Sebastian Marwitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Marwitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Marwitz. The network helps show where Sebastian Marwitz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Sebastian Marwitz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sebastian Marwitz Line = papers co-authored together Sebastian Marwitz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20243
2 202222
3 20218
4 202118
5 202030
6 20191
7 201829
8 201814
9 20185
10 201826
11 201857
12 201754
13 201710
14 201676
15 201512
16 201568
17 201313
18 20116
19 201050
20 20094

About Sebastian Marwitz

Sebastian Marwitz is a scholar working on Immunology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 766 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (9 papers), Neonatal Respiratory Health Research (8 papers), Epigenetics and DNA Methylation (7 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers), RNA modifications and cancer (4 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers) and Asthma and respiratory diseases (4 papers). The work is most often cited by research in Microbiology (86 citations), Immunology (230 citations) and Cancer Research (127 citations). Sebastian Marwitz has collaborated with scholars based in Germany, United States and Sweden. Frequent co-authors include Torsten Goldmann, Christian Kügler, Klaus F. Rabe, Ole Ammerpohl, Daniel Drömann, Martin Reck, Martin Reck, Sven Perner, Ekkehard Vollmer and P. Zabel. Their work appears in journals such as PLoS ONE, Cancer Research and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026